galantamine hydrobromide 24 MG 24 HR Extended Release Oral Capsule

RxCUI
860707
RxNorm name
galantamine hydrobromide 24 MG 24 HR Extended Release Oral Capsule
Display name
galantamine hydrobromide 24 MG 24 HR Extended Release Oral Capsule
Full name
galantamine hydrobromide 24 MG 24 HR Extended Release Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:55

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Galantamine HydrobromideGALANTAMINE HYDROBROMIDEBryant Ranch Prepack0f74a146-f6ee-4910-82a3-177153526dd02025-09-12Warnings, Adverse reactionsExact identifier
rxcui: 860707
Galantamine HydrobromideGALANTAMINE HYDROBROMIDEBryant Ranch Prepack3e7e2839-a834-4464-a82a-7554e10ad0042024-08-12Warnings, Adverse reactionsExact identifier
rxcui: 860707
GalantamineGALANTAMINEAurobindo Pharma Limitedd0b75970-8d3d-408b-9e17-9cbad0f776b12024-01-30Warnings, Adverse reactionsExact identifier
rxcui: 860707
Galantamine HydrobromideGALANTAMINE HYDROBROMIDESun Pharmaceutical Industries, Inc.d1697161-ebe8-42b0-83e7-c9de4412546c2023-10-26Warnings, Adverse reactionsExact identifier
rxcui: 860707

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3e7e2839-a834-4464-a82a-7554e10ad004galantamine HBr 24 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR galantamine hydrobromide 24 MG Extended Release Oral Capsule [SCD] · galantamine hydrobromide 24 MG 24 HR Extended Release Oral Capsule [SY]3107These highlights do not include all the information needed to use GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES. GALANTAMINE HYDROBROMIDE extended-release capsules, for oral use Initial U.S. Approval: 200120240812
0f74a146-f6ee-4910-82a3-177153526dd0galantamine HBr 24 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR galantamine hydrobromide 24 MG Extended Release Oral Capsule [SCD] · galantamine hydrobromide 24 MG 24 HR Extended Release Oral Capsule [SY]3102These highlights do not include all the information needed to use GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES. GALANTAMINE HYDROBROMIDE extended-release capsules, for oral use Initial U.S. Approval: 200120250912
d1697161-ebe8-42b0-83e7-c9de4412546cgalantamine HBr 24 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR galantamine hydrobromide 24 MG Extended Release Oral Capsule [SCD] · galantamine hydrobromide 24 MG 24 HR Extended Release Oral Capsule [SY]317These highlights do not include all the information needed to use GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES. GALANTAMINE HYDROBROMIDE extended-release capsules, for oral use Initial U.S. Approval: 200120231026
d0b75970-8d3d-408b-9e17-9cbad0f776b1galantamine HBr 24 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR galantamine hydrobromide 24 MG Extended Release Oral Capsule [SCD] · galantamine hydrobromide 24 MG 24 HR Extended Release Oral Capsule [SY]311These highlights do not include all the information needed to use GALANTAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for GALANTAMINE EXTENDED-RELEASE CAPSULES. GALANTAMINE extended-release capsules, for oral use Initial U.S. Approval: 200120240130